Long-term follow-up study of VenusP-Valve heart device
Part of Heart & circulation clinical trials.
This study follows patients who received the VenusP-Valve™ System (an artificial heart valve) 6–10 years ago to check how well it's working over time and ensure it remains safe.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You received a VenusP-Valve™ System implant 6–10 years ago
- You are willing to participate in a long-term follow-up study
- You can provide informed consent or have a legal representative who can consent for you
- Your doctor believes you are suitable to participate in this study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This observational study follows people who need a pulmonary valve treatment, to see how the Venus P-Valve works in real-world care. It may help doctors understand which patients benefit and how outcomes change over time.
This study follows people who previously had the VitaFlow transcatheter aortic valve placed to learn how it does long-term. It may help doctors understand long-term safety and performance for this valve system.
This study tests a new less-invasive heart valve (VenusP-Valve) for people whose own pulmonary valve is leaking severely. If you qualify, you could get the new valve without open-heart surgery.
This trial tests a new heart valve device (Venus-Vitae) for people with severe aortic stenosis, a condition where the heart valve is too tight. It aims to see if the device works well for patients of all surgical risk levels.
This study looks back at patients who were successfully treated with TricValve bicaval valve devices and then follows up with their outcomes. You might join if you (or your legal guardian) agree to be included.
This study tests an early, first-use version of a new pulmonary valve device for children whose own valve is not working well. It may help improve blood flow from the heart to the lungs and aims to learn how safe and effective the valve is over time.
Hear when a new Native Right Ventricle Outflow Tract(RVOT) Dysfunction trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.